from PET30 to rPET30 liners

Sustainable pharma solutions - making the switch from PET30 to rPET30 liners

Every small step towards sustainability matters, so we are accelerating our mission to make a difference in the pharmaceutical labeling space. Guided by a strong belief in doing our part for the planet and patients, we're evolving our practices to embrace recycled PET (rPET) liners across our pharmaceutical portfolio by the end of 2025. With this transition, all PET30 and PET23 liners will be converted to rPET grades with 30% post-consumer recycled material. 

By doing so, our customers will also directly benefit, as this is a tangible way to achieve their own sustainability goals. This shift helps reduce scope three emissions and positively impacts their carbon footprint, while also demonstrating a genuine commitment.

This focus is not new; it's a core part of our DNA. Over recent years, we have developed expertise and achieved progress in incorporating rPET liners across some of our portfolio. And the integration of rPET liners with our S692NP adhesive, highlights our forward-looking approach to sustainable labeling solutions tailored for the pharmaceutical industry.

This strategic shift is driven by the need to reduce pharmaceutical packaging's environmental footprint proactively. Recognizing the industry's understandably cautious stance towards change, particularly when patient safety is at stake, we've designed a transition strategy that ensures a smooth, secure, and hassle-free process for our customers. In alignment with our Pharma Change Management protocols, we are providing a 12-month period for the necessary validation processes. 

In addition to these measures, we're happy to offer the AD Circular program, which complements our move to rPET30 liners, amplifying the environmental benefits. AD Circular is our service for recycling used filmic and paper label liners in European countries. With it, we are implementing a new way to enable the recycling of labels and packaging (regardless of their origin) and advancing the use of recycled materials. By completing this transition, we anticipate generating substantial annual savings: approximately 532,000KG of CO2 and 2,266,000 liters of water*.

from PET30 to rPET30 liners

Target applications and key features

Our rPET liners are suitable for demanding applications within the pharmaceutical industry, including syringes, eye drops, insulin pens, and security seals. 

We are confident in the quality of our products, making sure they meet the stringent demands of pharmaceutical applications without compromising patient safety or wellbeing.

Key features:

  • No impact on the conversion or label dispensing process, ensuring operational continuity for our customers.

  • The 30% PCR layer is encapsulated between two outer layers of virgin material

  • The silicone coating, crucial for consistent label application, retains quality and performance.

  • Certification under the Global Recycled Standard (GRS), highlighting our commitment to sustainable manufacturing practices.

We are happy to work with you to find the best label material that helps your brand meet its sustainability goals. Please contact Benoit Jourde, Business Development Manager Pharmaceutical & Healthcare, for more information.

Additionally, if you want to learn more about the AD Circular program, please visit our dedicated website.

*Based on our 2023 sales volumes and calculations from the Carbon Trust tool version  January 2024.